Alzheimer's Research

We are delighted to welcome 15 new residents, who matched to our diagnostic radiology and integrated IR residency programs and will join UCSF Department of Radiology and Biomedical Imaging in...

Endothelial cells are enriched in genes associated with genetic risk for ADOur analyses were based on data from 77 cortical brain samples from donors with AD (n = 41) or non-diseased controls (NDC, n = 36). Three different...

Participant characteristicsA total of 548 participants in the BioFINDER-2 cohort met the criteria to be included in the present analysis based on the availability of at least one of the plasma biomarkers listed below...

Identification of neuropsychiatric signs and symptoms and exploration of the labeled dataWe have established a computational pipeline that consists of text parsers and NLP models to convert the extensive medical record summaries into clinical...

In recent years, significant advancements have been made in understanding the pathogenesis of Alzheimer's disease (AD) through the accumulation and monitoring of biomarkers, shedding light on the accumulation and prevalence of AD pathology. Blood...

Early stages of neurodegenerative disorders are characterized by the accumulation of proteins in discrete populations of brain cells and degeneration of these cells. For most diseases, this selective vulnerability pattern is unexplained, yet it...

Maryana was over-the-moon to be a mom for the first time when she learned she was pregnant in May 2022. Energetic and lively, Maryana was taken by surprise when she...

Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating -- a condition commonly known as "chemo brain." MIT researchers have now shown that a noninvasive treatment that stimulates gamma frequency...

When AI leverages large amounts of data it can be used to produce diagnostic tools that help locate abnormalities faster and more accurately. However, for patients with diseases like multiple...

Participants and dataThis is a natural history, non-interventional study of cognitively normal individuals ages 35–65 years, carrying risk factors for late-onset AD such as a family history and/or APOE4 genotype. Participants were recruited at the...